rs755043940
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BS1_Supporting
The NM_181523.3(PIK3R1):c.202G>A(p.Asp68Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,842 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D68H) has been classified as Uncertain significance.
Frequency
Consequence
NM_181523.3 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency 36 with lymphoproliferationInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
- SHORT syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
- agammaglobulinemia 7, autosomal recessiveInheritance: AR Classification: STRONG, LIMITED Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- activated PI3K-delta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- autosomal agammaglobulinemiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PIK3R1 | NM_181523.3 | c.202G>A | p.Asp68Asn | missense_variant | Exon 2 of 16 | ENST00000521381.6 | NP_852664.1 | |
| PIK3R1 | XM_005248542.4 | c.202G>A | p.Asp68Asn | missense_variant | Exon 2 of 16 | XP_005248599.1 | ||
| PIK3R1 | XM_017009585.3 | c.202G>A | p.Asp68Asn | missense_variant | Exon 2 of 16 | XP_016865074.1 | ||
| PIK3R1 | XM_047417315.1 | c.202G>A | p.Asp68Asn | missense_variant | Exon 2 of 16 | XP_047273271.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000797 AC: 2AN: 250954 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461842Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727228 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
SHORT syndrome;C3554689:Agammaglobulinemia 7, autosomal recessive;C4014934:Immunodeficiency 36 with lymphoproliferation Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces aspartic acid with asparagine at codon 68 of the PIK3R1 protein (p.Asp68Asn). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and asparagine. This variant is present in population databases (rs755043940, ExAC 0.009%). This variant has not been reported in the literature in individuals with PIK3R1-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). -
Activated PI3K-delta syndrome Benign:1
The PIK3R1 c.202G>A (p.Asp68Asn) variant results in a missense substitution of aspartic acid to asparagine at codon 68. This residue is not within a known critical functional domain of the PIK3R1 protein. The variant is extremely rare, with a gnomAD allele frequency of 0.00000342, consistent with a benign classification for rare disorders. Immune profiling revealed T follicular helper (TFH) cells at 15.7%, which falls within the normal range, while transitional B cells were elevated at 22.7%. Although this increase may indicate some immune deviation, it is not specific for PIK3R1-associated disease and was not accompanied by activation of the mTOR signaling pathway, suggesting intact PI3K pathway regulation. Computational predictions provide mixed but non-concerning evidence: REVEL classifies the variant as Benign Moderate (0.295), and AlphaMissense yields an Uncertain score (0.4969), which does not support pathogenicity. There are no published studies linking this variant to disease. Taking into account the normal mTOR signaling, largely unremarkable immune profile, rarity of the variant, and benign computational support, this is best classified as Likely Benign -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at